Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Sage Therapeutic Com
(NQ:
SAGE
)
13.94
+0.83 (+6.33%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sage Therapeutic Com
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Sage Therapeutics Appoints Chris Benecchi as Chief Commercial Officer
September 21, 2021
From
Sage Therapeutics
Via
Business Wire
Why Sage Therapeutics Shares Are Trading Higher Today
September 15, 2021
Sage Therapeutics (NASDAQ:SAGE) shares are trading higher after the company announced it received Fast Track Designation for SAGE-718 or the treatment of Huntington's...
Via
Benzinga
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
September 15, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) Alcon Inc. (NYSE: ALC)...
Via
Benzinga
Exposures
COVID-19
Where Sage Therapeutics Stands With Analysts
August 04, 2021
Analysts have provided the following ratings for Sage Therapeutics (NASDAQ:SAGE...
Via
Benzinga
Analyst Ratings For Sage Therapeutics
July 29, 2021
Analysts have provided the following ratings for Sage Therapeutics (NASDAQ:
Via
Benzinga
Sage Therapeutics Receives Fast Track Designation for SAGE-718 for the Treatment of Huntington’s Disease
September 15, 2021
From
Sage Therapeutics, Inc.
Via
Business Wire
Sage Therapeutics to Present at the Morgan Stanley Global Healthcare Conference
September 02, 2021
From
Sage Therapeutics, Inc.
Via
Business Wire
5 Value Stocks In The Healthcare Sector
August 23, 2021
The Meaning Behind Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E...
Via
Benzinga
Overview Of Value Stocks In The Healthcare Sector
August 16, 2021
Understanding Value Stocks A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...
Via
Benzinga
The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
July 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc...
Via
Benzinga
Exposures
COVID-19
Stocks That Hit 52-Week Lows On Friday
August 20, 2021
On Friday morning, 155 companies achieved new lows for the year. Interesting Points: Marqeta (NASDAQ:MQ) was the largest firm on a market cap basis to set a new 52-...
Via
Benzinga
A Look Into Healthcare Sector Value Stocks
August 09, 2021
What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...
Via
Benzinga
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
August 20, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS...
Via
Benzinga
Exposures
COVID-19
Sage Therapeutics to Present at Upcoming August Investor Conferences
August 04, 2021
From
Sage Therapeutics, Inc.
Via
Business Wire
10 Biggest Price Target Changes For Wednesday
August 04, 2021
Baird boosted the price target for Lululemon Athletica Inc. (NASDAQ:
Via
Benzinga
Sage Therapeutics Inc (SAGE) Q2 2021 Earnings Call Transcript
August 03, 2021
SAGE earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Sage Therapeutics Drops Two Zuranolone Depression Trials Deemed Unnecessary For Approval
August 03, 2021
Tucked in the Q2 earnings release, Sage Therapeutics Inc (NASDAQ: SAGE) has terminated two long-suspended Phase 3 zuranolone trials in major depressive disorder (MDD)....
Via
Benzinga
Sage Therapeutics: Q2 Earnings Insights
August 03, 2021
Shares of Sage Therapeutics (NASDAQ:SAGE) moved higher by 11.9% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 12...
Via
Benzinga
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
August 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
August 03, 2021
On Tuesday morning, 69 companies achieved new lows for the year. Intriguing Points: Las Vegas Sands (NYSE:LVS) was the largest firm by market cap to set a new 52-...
Via
Benzinga
Sage Therapeutics Announces Second Quarter 2021 Financial Results and Highlights Pipeline and Business Progress
August 03, 2021
From
Sage Therapeutics, Inc.
Via
Business Wire
Earnings Scheduled For August 3, 2021
August 03, 2021
Companies Reporting Before The Bell • Myriad Genetics (NASDAQ:MYGN) is likely to report earnings for its fourth quarter. • Stellantis (NYSE:STLA) is expected to...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
July 27, 2021
During Tuesday's morning session, 216 companies made new 52-week lows. Noteworthy Points: Alibaba Group Holding (NYSE:BABA) was the largest firm by market cap...
Via
Benzinga
The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts
July 27, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 26) Absci, CORP (NASDAQ: ABSI...
Via
Benzinga
Sage Therapeutics to Report Second Quarter 2021 Financial Results on Tuesday, August 3, 2021
July 20, 2021
From
Sage Therapeutics, Inc.
Via
Business Wire
Sage Therapeutics to Participate in Cowen’s Psychedelics & Novel Mechanisms in Neuropsychiatry Summit
July 08, 2021
From
Sage Therapeutics, Inc.
Via
Business Wire
June’s Best and Worst Performing Russell 1,000 Stocks
June 29, 2021
The month of June, the second quarter and the first half of 2021 are almost in the bag.
Via
Talk Markets
How Bad Is Biogen's Latest Bad News?
June 29, 2021
The drugmaker has had one big clinical setback and another less serious disappointment in recent weeks.
Via
The Motley Fool
Sage Therapeutics to Participate in SVB Leerink’s 3rd Annual CNS Forum
June 24, 2021
From
Sage Therapeutics, Inc.
Via
Business Wire
What Happened to Sage Therapeutics Stock?
June 21, 2021
Sage has been struggling for some time to bring its flagship antidepressant to the market.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.